Epidemiological update: A(H7N9) influenza virus, China, 19 December 2013
In March 2013, Chinese authorities announced the identification of a novel reassortant A(H7N9) avian influenza virus in patients in eastern China.
Epidemiological update: avian influenza A(H5N1), 8 January 2014
On 8 January 2014, Canada reported a fatal imported case of influenza A(H5N1) infection. This is the first confirmed human case of H5N1 in North America.
Epidemiological update A(H7N9) influenza, 6 February 2014
In March 2013, Chinese authorities announced the identification of a novel reassortant A(H7N9) influenza virus in patients in eastern China. Since then, human cases have continued to be reported, and as of 7 February 2014 (Figure 1), there have been 308 laboratory-confirmed cases: Zhejiang (122), Guangdong (54), Shanghai (42), Jiangsu (36), Fujian (19), Hunan (7), Jiangxi (5), Henan (4), Anhui (4) ,Beijing (3), Shandong (2), Hebei (1), Guangxi (2), Guizhou (1), Hong Kong (4) and Taiwan (2). In addition, the virus has been detected in one asymptomatic case in Beijing.
Very low public health threat related to outbreak of avian influenza A(H5N8) in turkeys in Germany
The risk of transmission of avian influenza A(H5N8) to the general public in the EU/EEA countries is extremely low.
Epidemiological update: increase in reporting of human cases of A(H5N1) influenza, Egypt, 9 April 2015
Epidemiological update: increase in reporting of human cases of A(H5N1) influenza, Egypt
Influenza surveillance for the 2017-2018 season is starting
ECDC monitors and reports on influenza transmission and virus circulation in Europe on a weekly basis throughout the flu season, in collaboration with WHO Regional Office for Europe, in the report Flu News Europe.
Cross-species avian influenza among mammalians - report of fatal avian influenza in New England harbour sealsArchived
This academic article describes virological findings and pathological consequences of a strain of influenza A(H3N8) recently identified as part of the investigations of an outbreak of pneumonia among harbour seals in New England in the autumn.
Influenza A(H7N9) virus gains neuraminidase inhibitor resistance without loss of in vivo virulence or transmissibility
Without baseline human immunity to the emergent avian influenza A(H7N9) virus, neuraminidase inhibitors are vital for controlling viral replication in severe infections.
FLURISK project proposes a model to rank animal influenza strains by their potential to infect humans
The final report of the FLURISK project by the European Food Safety Authority (EFSA) proposes a risk assessment framework to rank animal influenza strains according to their potential to infect humans.